LncRNA SOX21 ‐ AS1 Promotes the Progression of Pancreatic Cancer by Sponging miR ‐9‐3p and Upregulating YOD1
The Kaohsiung Journal of Medical Sciences · 2025
DOI: 10.1002/kjm2.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Han-Bing Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Pancreatic Gastrointestinal Surgery, Wuhan Third Hospital, Wuhan, China. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms, RNA, Long Noncoding. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic cancer (PC) is a highly aggressive malignancy of the digestive system. Recent studies have indicated that the long noncoding RNA SOX21‐AS1 is significantly upregulated in PC tissue samples. This study aims to elucidate the biological role and underlying molecular mechanisms of SOX21‐AS1 in PC progression. Quantitative real‐time PCR (qRT‐PCR) and western blot analyses were employed to assess RNA and protein expression levels, respectively. The subcellular localization of SOX21‐AS1 was determined using subcellular fractionation assays. PC cell viability, migratory capacity, and apoptosis were evaluated through CCK‐8 assays, wound healing assays, and flow cytometry. Dual‐luciferase reporter and RNA pull‐down assays were conducted to confirm the interactions between miR‐9‐3p and either SOX21‐AS1 or YOD1. Additionally, a xenograft mouse model was established to investigate the in vivo effects of SOX21‐AS1. The findings revealed that SOX21‐AS1 is highly expressed in PC tissues and cell lines, with its upregulation correlating with poor patient prognosis. Functional assays demonstrated that knockdown of SOX21‐AS1 suppressed PC cell proliferation and migration, induced apoptosis in vitro, and reduced tumor growth in vivo. Mechanistically, SOX21‐AS1 competitively interacted with miR‐9‐3p to upregulate YOD1, consequently activating the TGF‐β/Smad signaling pathway. Furthermore, overexpression of YOD1 reversed the tumor‐suppressive effects observed after SOX21‐AS1 knockdown. In conclusion, SOX21‐AS1 promotes PC cell malignancy through the miR‐9‐3p/YOD1 axis and subsequent activation of TGF‐β/Smad signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Pancreatic Gastrointestinal Surgery, Wuhan Third Hospital, Wuhan, China.
- Department of Gastrointestinal Abdominal Wall and Hernia Surgery, Wuhan Third Hospital, Wuhan, China.
ORCID-Profile: Bin Jiang
Zitieren
APA
Xu, H. B., Han, J. T., Zhang, C. P., & Jiang, B. (2025). LncRNA SOX21 ‐ AS1 Promotes the Progression of Pancreatic Cancer by Sponging miR ‐9‐3p and Upregulating YOD1. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70054
Vancouver
Xu HB, Han JT, Zhang CP, Jiang B. LncRNA SOX21 ‐ AS1 Promotes the Progression of Pancreatic Cancer by Sponging miR ‐9‐3p and Upregulating YOD1. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70054
BibTeX
@article{Xu2025,
author = {Xu, Han-Bing and Han, Jian-Tao and Zhang, Cheng-Peng and Jiang, Bin},
title = {LncRNA SOX21 ‐ AS1 Promotes the Progression of Pancreatic Cancer by Sponging miR ‐9‐3p and Upregulating YOD1},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
doi = {10.1002/kjm2.70054}
}
EUVIMED